Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Enanta Pharmaceuticals Inc.
DescriptionCyclophilin inhibitor
Molecular Target Cyclophilin
Mechanism of ActionCyclophilin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV genotypes 1 and 3 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today